The Global Phosphoramidite Market is estimated to be valued at US$ 1,011.3 MN in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Global Phosphoramidite Market are Glen Research, ChemGenes Corporation, Link Technologies Ltd., BioAutomation Corporation, Merck KGaA, Sigma-Aldrich (now part of MilliporeSigma, a Merck Group company), LGC Biosearch Technologies, Thermo Fisher Scientific, Biosynthesis Inc., ATDBio Ltd., Genscript Biotech Corporation, Expedeon AG, Wuxi Donglin Sci & Tech Development Co., Ltd., Bio-Synthesis Inc., and ChemGenes Corporation.

The demand for phosphoramidite monomers is growing owing to the increasing applications of DNA sequencing technologies in the fields of genetic research, diagnostics, forensic analysis and monitoring genetic variations related to diseases. As per estimates, Global Phosphoramidite Market Size is expected to reach over US$ 60 Billion by 2026.

The major phosphoramidite producers are focusing on expanding their geographic footprint by strengthening their distribution networks across Americas, Europe, Asia Pacific and rest of world regions where robust growth is witnessed in genetic analysis research and laboratories. Regional production facilities are also being set up by key players to ensure security of supply and timely delivery.

Get More Insights on Phosphoramidite Market